Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ)
CNY 5.49
(0.37%)
CNY 5.49
(0.37%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.91 Billion CNY | -16.16% |
| 2022 | 2.28 Billion CNY | 20.03% |
| 2021 | 1.9 Billion CNY | 43.71% |
| 2020 | 1.32 Billion CNY | 29.7% |
| 2019 | 1.02 Billion CNY | -37.82% |
| 2018 | 1.64 Billion CNY | -29.25% |
| 2017 | 2.32 Billion CNY | 8.88% |
| 2016 | 2.13 Billion CNY | 69.73% |
| 2015 | 1.25 Billion CNY | 27.24% |
| 2014 | 988.73 Million CNY | -33.05% |
| 2013 | 1.47 Billion CNY | 25.15% |
| 2012 | 1.17 Billion CNY | 69.01% |
| 2011 | 698.17 Million CNY | 39.0% |
| 2010 | 502.28 Million CNY | 15.6% |
| 2009 | 434.48 Million CNY | -6.68% |
| 2008 | 465.57 Million CNY | 13.09% |
| 2007 | 411.69 Million CNY | 2.24% |
| 2006 | 402.66 Million CNY | 2.26% |
| 2005 | 393.75 Million CNY | 54.2% |
| 2004 | 255.34 Million CNY | -7.94% |
| 2003 | 277.35 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.11 Billion CNY | 10.2% |
| 2024 Q2 | 2.14 Billion CNY | 1.47% |
| 2024 Q3 | 2.14 Billion CNY | 0.2% |
| 2023 Q1 | 2.91 Billion CNY | 27.26% |
| 2023 FY | 1.91 Billion CNY | -16.16% |
| 2023 Q4 | 1.91 Billion CNY | -23.57% |
| 2023 Q3 | 2.51 Billion CNY | -5.55% |
| 2023 Q2 | 2.65 Billion CNY | -8.74% |
| 2022 Q4 | 2.28 Billion CNY | -6.16% |
| 2022 FY | 2.28 Billion CNY | 20.03% |
| 2022 Q1 | 1.77 Billion CNY | -7.03% |
| 2022 Q2 | 2.24 Billion CNY | 26.62% |
| 2022 Q3 | 2.43 Billion CNY | 8.66% |
| 2021 Q3 | 1.78 Billion CNY | 3.84% |
| 2021 Q4 | 1.9 Billion CNY | 6.57% |
| 2021 FY | 1.9 Billion CNY | 43.71% |
| 2021 Q1 | 1.55 Billion CNY | 16.99% |
| 2021 Q2 | 1.72 Billion CNY | 11.0% |
| 2020 Q3 | 1.1 Billion CNY | -15.15% |
| 2020 FY | 1.32 Billion CNY | 29.7% |
| 2020 Q4 | 1.32 Billion CNY | 19.62% |
| 2020 Q1 | 987.26 Million CNY | -3.47% |
| 2020 Q2 | 1.3 Billion CNY | 32.38% |
| 2019 Q2 | 1.08 Billion CNY | -45.78% |
| 2019 FY | 1.02 Billion CNY | -37.82% |
| 2019 Q4 | 1.02 Billion CNY | -6.71% |
| 2019 Q3 | 1.09 Billion CNY | 0.81% |
| 2019 Q1 | 2 Billion CNY | 21.93% |
| 2018 FY | 1.64 Billion CNY | -29.25% |
| 2018 Q1 | 1.96 Billion CNY | -15.62% |
| 2018 Q4 | 1.64 Billion CNY | 8.95% |
| 2018 Q3 | 1.5 Billion CNY | -15.67% |
| 2018 Q2 | 1.79 Billion CNY | -8.74% |
| 2017 Q1 | 2.33 Billion CNY | 9.31% |
| 2017 Q4 | 2.32 Billion CNY | 7.26% |
| 2017 Q3 | 2.16 Billion CNY | 13.63% |
| 2017 Q2 | 1.9 Billion CNY | -18.27% |
| 2017 FY | 2.32 Billion CNY | 8.88% |
| 2016 Q3 | 1.88 Billion CNY | -3.55% |
| 2016 Q4 | 2.13 Billion CNY | 13.49% |
| 2016 Q1 | 1.52 Billion CNY | 21.45% |
| 2016 FY | 2.13 Billion CNY | 69.73% |
| 2016 Q2 | 1.95 Billion CNY | 27.66% |
| 2015 FY | 1.25 Billion CNY | 27.24% |
| 2015 Q1 | 782.07 Million CNY | -20.9% |
| 2015 Q2 | 785.3 Million CNY | 0.41% |
| 2015 Q3 | 877.09 Million CNY | 11.69% |
| 2015 Q4 | 1.25 Billion CNY | 43.43% |
| 2014 Q1 | 1.51 Billion CNY | 2.86% |
| 2014 Q2 | 1.53 Billion CNY | 1.23% |
| 2014 Q3 | 1.46 Billion CNY | -4.79% |
| 2014 Q4 | 988.73 Million CNY | -32.46% |
| 2014 FY | 988.73 Million CNY | -33.05% |
| 2013 FY | 1.47 Billion CNY | 25.15% |
| 2013 Q4 | 1.47 Billion CNY | 5.84% |
| 2013 Q3 | 1.39 Billion CNY | 2.32% |
| 2013 Q2 | 1.36 Billion CNY | 9.03% |
| 2013 Q1 | 1.25 Billion CNY | 5.99% |
| 2012 Q2 | 824.29 Million CNY | 19.15% |
| 2012 Q1 | 691.79 Million CNY | -0.91% |
| 2012 FY | 1.17 Billion CNY | 69.01% |
| 2012 Q4 | 1.17 Billion CNY | 14.34% |
| 2012 Q3 | 1.03 Billion CNY | 25.19% |
| 2011 Q1 | 565.8 Million CNY | 12.65% |
| 2011 FY | 698.17 Million CNY | 39.0% |
| 2011 Q4 | 698.17 Million CNY | 10.3% |
| 2011 Q3 | 632.96 Million CNY | -4.68% |
| 2011 Q2 | 664.01 Million CNY | 17.36% |
| 2010 Q2 | 485.64 Million CNY | 6.77% |
| 2010 Q3 | 492.06 Million CNY | 1.32% |
| 2010 FY | 502.28 Million CNY | 15.6% |
| 2010 Q4 | 502.28 Million CNY | 2.08% |
| 2010 Q1 | 454.83 Million CNY | 4.69% |
| 2009 Q3 | 408.94 Million CNY | -14.07% |
| 2009 Q2 | 475.9 Million CNY | -9.96% |
| 2009 FY | 434.48 Million CNY | -6.68% |
| 2009 Q1 | 528.52 Million CNY | 13.52% |
| 2009 Q4 | 434.48 Million CNY | 6.24% |
| 2008 Q2 | 413.5 Million CNY | 11.8% |
| 2008 Q3 | 388.17 Million CNY | -6.13% |
| 2008 Q4 | 465.57 Million CNY | 19.94% |
| 2008 FY | 465.57 Million CNY | 13.09% |
| 2008 Q1 | 369.86 Million CNY | -10.16% |
| 2007 Q3 | 333.88 Million CNY | -10.01% |
| 2007 Q2 | 371.02 Million CNY | 8.58% |
| 2007 Q4 | 411.69 Million CNY | 23.31% |
| 2007 Q1 | 341.72 Million CNY | -15.13% |
| 2007 FY | 411.69 Million CNY | 2.24% |
| 2006 FY | 402.66 Million CNY | 2.26% |
| 2006 Q4 | 402.66 Million CNY | -14.12% |
| 2006 Q2 | 469.37 Million CNY | 0.0% |
| 2006 Q3 | 468.84 Million CNY | -0.11% |
| 2005 Q4 | 393.75 Million CNY | 0.0% |
| 2005 FY | 393.75 Million CNY | 54.2% |
| 2004 FY | 255.34 Million CNY | -7.94% |
| 2003 FY | 277.35 Million CNY | 0.0% |